Nitta Gelatin India Limited (NITTAGELA) Share Price
NSE · Basic Materials · Specialty Chemicals · ISIN INE265B01019
Key metrics
- Market Cap
- ₹1,504 Cr
- P/E Ratio
- 14.47
- EPS
- 114.44
- Book Value
- 567.76
- P/B Ratio
- 2.92
- ROE
- 18.86%
- ROCE
- 23.66%
- Debt / Equity
- 0.01
- Net Margin
- 17.11%
- Revenue Growth
- 9.9%
- Profit Growth
- 15.85%
- Dividend Yield
- 0.44%
- 52W High
- ₹2,087.20
- 52W Low
- ₹882.00
- Market Cap Band
- small cap
- Face Value
- 10
Ratios computed from the annual results period ending 2026-03-31.
About Nitta Gelatin India Limited
Nitta Gelatin India Limited engages in the manufacture and sale of ossein, gelatin, and collagen peptide in India and internationally. It offers wellnex collagen peptides for collagen peptide absorption, diabetes management, bones and joints, and beauty products; gelatin for pharmaceutical and edible applications; and Di Calcium Phosphate for use in poultry feed. The company provides chitosan for food, pharmaceutical, textile, agriculture, water treatment, and cosmetics industries, as well as ossein. It also exports its products. The company was formerly known as Kerala Chemicals & Proteins Limited and changed its name to Nitta Gelatin India Limited in 2008. Nitta Gelatin India Limited was incorporated in 1975 and is based in Kochi, India.
- Headquarters
- Kochi, India
- Employees
- 471
- Promoter Holding
- 74.48%
The full Nitta Gelatin India Limited analysis
Create a free account to open the complete NITTAGELA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.